{"id":"W4402560836","doi":"10.1016/j.annonc.2024.08.1269","title":"1210P Neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy and adjuvant pembro or pbo for early stage NSCLC: Subgroup analyses of the phase III KEYNOTE-671 study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Adjuvant; Placebo; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Alternative medicine; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002821432,0.001973543,0.004040917,0.0004501186,0.0003391922,0.001408314,0.0008550024,0.001199182,0.003865054],"category_scores_gemma":[0.002917586,0.0008119313,0.008945819,0.0007429269,0.0005207572,0.001056942,0.0008063948,0.003098612,0.0006272012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009828144,"about_ca_system_score_gemma":0.001071287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001706932,"about_ca_topic_score_gemma":0.005570617,"domain_scores_codex":[0.9986964,0.0007328045,0.000100487,0.0002082109,0.00008797482,0.000174138],"domain_scores_gemma":[0.9990684,0.0003773,0.0002190451,0.0001517258,0.00004913787,0.0001343969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9210726,0.0006537149,0.007032556,0.002540812,0.04512357,0.0000976707,0.00006272919,0.001293371,0.003038219,0.0002074282,0.002712644,0.01616471],"study_design_scores_gemma":[0.7802778,0.04098275,0.0494069,0.0004962157,0.1169348,0.0002623305,0.0002659656,0.002283873,0.001611547,0.001761455,0.005582717,0.0001335049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9486454,0.03508684,0.001684623,0.001177634,0.001093802,0.001736574,0.006625738,0.0001517299,0.00379783],"genre_scores_gemma":[0.9856591,0.004771563,0.000785856,0.0008871886,0.0003678875,0.001172734,0.003698524,0.00005233487,0.002604888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004040917,"threshold_uncertainty_score":0.01492131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1386326968691451,"score_gpt":0.5114329727693283,"score_spread":0.3728002759001832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}